Embecta Corp. to Issue Quarterly Dividend of $0.01 (NASDAQ:EMBC)

Embecta Corp. (NASDAQ:EMBC) declared a quarterly dividend on Friday, August 7th. Stockholders of record on Thursday, August 27th will be given a dividend of 0.01 per share on Tuesday, September 15th. This represents a c) annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, August 27th.

Embecta has a payout ratio of 1.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Embecta to earn $1.75 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.3%.

Embecta Trading Up 26.3%

Shares of EMBC stock traded up $0.92 during trading hours on Friday, hitting $4.42. 5,586,683 shares of the company were exchanged, compared to its average volume of 1,573,631. The business has a 50 day moving average of $3.32 and a two-hundred day moving average of $6.67. Embecta has a 52 week low of $2.77 and a 52 week high of $15.55. The company has a market capitalization of $262.24 million, a PE ratio of 2.33 and a beta of 0.81.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.29. The business had revenue of $271.70 million for the quarter, compared to analyst estimates of $254.53 million. Embecta had a net margin of 10.73% and a negative return on equity of 23.96%. The firm’s quarterly revenue was down 8.1% on a year-over-year basis. During the same period last year, the business posted $1.12 earnings per share. Embecta has set its FY 2026 guidance at 1.800-1.900 EPS. On average, research analysts forecast that Embecta will post 1.62 EPS for the current year.

Institutional Investors Weigh In On Embecta

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC boosted its stake in shares of Embecta by 368.6% during the 3rd quarter. Larson Financial Group LLC now owns 2,001 shares of the company’s stock worth $28,000 after buying an additional 1,574 shares during the last quarter. One Wealth Advisors LLC acquired a new stake in shares of Embecta in the second quarter valued at about $33,000. Tower Research Capital LLC TRC increased its position in shares of Embecta by 542.6% in the second quarter. Tower Research Capital LLC TRC now owns 7,371 shares of the company’s stock valued at $71,000 after acquiring an additional 6,224 shares during the last quarter. Wexford Capital LP bought a new stake in Embecta during the third quarter worth about $94,000. Finally, Humankind Investments LLC bought a new stake in Embecta during the second quarter worth about $111,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

Embecta Company Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.